公开(公告)号：BR9907112A

公开(公告)日：2000-10-24

申请号：BR9907112

申请日：1999-01-23

Applicant: BASF AG

Inventor： BAUCKE DORIT ,  LAUNGE UDO ,  MACK HELMUT ,  SEITZ WERNER ,  HOFFKEN HANS WOLFGANG ,  HORNBERGER WILFRIED

IPC: A61K38/00 ,  A61P1/18 ,  A61P7/02 ,  A61P11/06 ,  A61P17/04 ,  A61P19/02 ,  A61P27/16 ,  A61P29/00 ,  C07K5/06 ,  C07K5/065 ,  A61K38/05

Abstract: Novel five-membered heterocyclic amidines, their preparation and use as competitive inhibitors of trypsin-like serine proteases, especially thrombin and kininogenases such as kallikrein. Pharmaceutical compositions which contain the compounds as active ingredients, and use of the compounds as thrombin inhibitors, anticoagulants and antiinflammatory agents.

公开(公告)号：NO20003814A

公开(公告)日：2000-07-25

申请号：NO20003814

申请日：2000-07-25

Applicant: BASF AG

Inventor： BAUCKE DORIT ,  LANGE UDO ,  MACK HELMUT ,  SEITZ WERNER ,  HOEFFKEN HANS WOLFGANG ,  HORNBERGER WILFRIED

IPC: A61K38/00 ,  A61P1/18 ,  A61P7/02 ,  A61P11/06 ,  A61P17/04 ,  A61P19/02 ,  A61P27/16 ,  A61P29/00 ,  C07K5/06 ,  C07K5/065 ,  C07K5/08 ,  A61K38/06

CPC classification number: C07K5/06191 ,  A61K38/00 ,  C07K5/06078

公开(公告)号：DK0808302T3

公开(公告)日：2000-07-17

申请号：DK96901746

申请日：1996-01-20

Applicant: BASF AG

Inventor： KARL ULRICH ,  SEITZ WERNER

IPC: C07B57/00 ,  C07C253/34 ,  C07C255/43

Abstract: PCT No. PCT/EP96/00236 Sec. 371 Date Jul. 7, 1997 Sec. 102(e) Date Jul. 7, 1997 PCT Filed Jan. 20, 1996 PCT Pub. No. WO96/23764 PCT Pub. Date Aug. 8, 1996A process for resolving the racemates of phenylacetonitriles of the formula I I where R1, R2, R3 and m have the meanings stated in the description is described. The process comprises dissolving the racemates I in a polar solvent, adding from 0.5 to 1.0 mol of optically active camphorsulfonic acid per mol of compound I, heating to 40 DEG -100 DEG C., allowing to cool and liberating the optically active phenylacetonitrile I from the salt obtained in this way.

公开(公告)号：ES2145427T3

公开(公告)日：2000-07-01

申请号：ES96901746

申请日：1996-01-20

Applicant: BASF AG

Inventor： KARL ULRICH ,  SEITZ WERNER

IPC: C07B57/00 ,  C07C253/34 ,  C07C255/43

Abstract: PCT No. PCT/EP96/00236 Sec. 371 Date Jul. 7, 1997 Sec. 102(e) Date Jul. 7, 1997 PCT Filed Jan. 20, 1996 PCT Pub. No. WO96/23764 PCT Pub. Date Aug. 8, 1996A process for resolving the racemates of phenylacetonitriles of the formula I I where R1, R2, R3 and m have the meanings stated in the description is described. The process comprises dissolving the racemates I in a polar solvent, adding from 0.5 to 1.0 mol of optically active camphorsulfonic acid per mol of compound I, heating to 40 DEG -100 DEG C., allowing to cool and liberating the optically active phenylacetonitrile I from the salt obtained in this way.

公开(公告)号：AU716319B2

公开(公告)日：2000-02-24

申请号：AU3694997

申请日：1997-07-14

Applicant: BASF AG

Inventor： MACK HELMUT ,  PFEIFFER THOMAS ,  SEITZ WERNER ,  ZIERKE THOMAS ,  BALKENHOHL FRIEDHELM ,  LANGE UDO

IPC: C12P17/04 ,  C07D207/22 ,  C07D401/12 ,  C12P17/10

Abstract: PCT No. PCT/EP97/03752 Sec. 371 Date Jan. 22, 1999 Sec. 102(e) Date Jan. 22, 1999 PCT Filed Jul. 14, 1997 PCT Pub. No. WO98/04523 PCT Pub. Date Feb. 5, 19983-Pyrroline-2-carboxylic acid derivatives of the formula I are prepared by eliminating the sulfonic acid residue, with the aid of a base, from a compound of the formula II

公开(公告)号：AT189458T

公开(公告)日：2000-02-15

申请号：AT95941015

申请日：1995-11-25

Applicant: BASF AG

Inventor： BOEHM HANS JOACHIM ,  KOSER STEFAN ,  MACK HELMUT ,  PFEIFFER THOMAS ,  SEITZ WERNER ,  HOEFFKEN HANS WOLFGANG ,  HORNBERGER WILFRIED ,  ZIERKE THOMAS

IPC: A61K38/00 ,  A61K38/05 ,  A61K38/55 ,  A61P7/02 ,  C07K5/06 ,  C07K5/062 ,  C07K5/065 ,  C07K5/072 ,  C07K5/087

公开(公告)号：BG103096A

公开(公告)日：1999-09-30

申请号：BG10309699

申请日：1999-01-19

Applicant: BASF AG

Inventor： BAUCKE DORIT ,  LANGE UDO ,  MACK HELMUT ,  SEITZ WERNER ,  ZIERKE THOMAS ,  HOEFFKEN HANS W ,  HORNBERGER WILFRIED

IPC: A61K38/00 ,  A61K38/05 ,  A61P7/02 ,  A61P29/00 ,  A61P35/00 ,  A61P35/04 ,  C07K5/06 ,  C07K5/062 ,  C07K5/065

Abstract: The invention relates to compounds with the formulawhere A,B,E & D have the meanings listed in the description, aswell as to their preparation. These compounds can be used for thetreatment of diseases.7 claims

公开(公告)号：SK899A3

公开(公告)日：1999-06-11

申请号：SK899

申请日：1997-07-29

Applicant: BASF AG

Inventor： BAUCKE DORIT ,  LANGE UDO ,  MACK HELMUT ,  SEITZ WERNER ,  ZIERKE THOMAS ,  HOFFKEN HANS W ,  HORNBERGER WILFRIED

IPC: A61K38/00 ,  A61K38/05 ,  A61P7/02 ,  A61P29/00 ,  A61P35/00 ,  A61P35/04 ,  C07K5/06 ,  C07K5/062 ,  C07K5/065

Abstract: PCT No. PCT/EP97/04104 Sec. 371 Date Feb. 10, 1999 Sec. 102(e) Date Feb. 10, 1999 PCT Filed Jul. 29, 1997 PCT Pub. No. WO98/06741 PCT Pub. Date Feb. 19, 1998Compounds of the formula where A, B, E and D have the meanings indicated in the description, and their preparation are described. The substances are suitable for controlling diseases.

公开(公告)号：NO990667L

公开(公告)日：1999-04-12

申请号：NO990667

申请日：1999-02-12

Applicant: BASF AG

Inventor： BAUCKE DORIT ,  LANGE UDO ,  MACK HELMUT ,  PFEIFFER THOMAS ,  SEITZ WERNER ,  ZIERKE THOMAS ,  HOEFFKEN HANS WOLFGANG ,  HORNBERGER WILFRIED

IPC: A61K31/40 ,  A61K31/44 ,  A61K38/00 ,  A61K38/05 ,  A61P1/18 ,  A61P7/02 ,  A61P11/02 ,  A61P11/06 ,  A61P17/00 ,  A61P19/02 ,  A61P29/00 ,  A61P43/00 ,  C07D207/22 ,  C07D211/78 ,  C07K5/00 ,  C07K5/02 ,  C07K5/083

Abstract: Compounds of the formula Iwhere R, R1, R2, R3, R4, R5 and R6, and l, m and n have the meanings stated in the description, and their preparation are described. The novel compounds are suitable for controlling diseases.

公开(公告)号：NZ288591A

公开(公告)日：1999-02-25

申请号：NZ28859195

申请日：1995-06-06

Applicant: BASF AG

Inventor： BOHM HANS-JOACHIM ,  KOSER STEFAN ,  MACK HELMUT ,  PFEIFFER THOMAS ,  SEITZ WERNER ,  HOFFKEN HANS WOLFGANG ,  HORNBERGER WILFRIED

IPC: A61K31/40 ,  A61K38/00 ,  A61K38/05 ,  A61K38/55 ,  A61K47/48 ,  A61P7/02 ,  C07C279/00 ,  C07D205/04 ,  C07D207/06 ,  C07D207/16 ,  C07D207/48 ,  C07D211/60 ,  C07K5/06 ,  C07K5/065 ,  C07K5/072 ,  C07K5/078 ,  C07D205/00

Abstract: Compounds of the formula and the salts thereof with physiologically tolerated acids and the stereoisomers thereof, in which the substituents have the meanings stated in the description, are described. Also disclosed are intermediates for their preparation. The compounds are suitable for controlling diseases.